Cava stock pops after blunder leads to early earnings release

Cava stock pops after blunder leads to early earnings release


A banner for the Mediterranean restaurant chain Cava is displayed outside of the New York Stock Exchange (NYSE) as the company goes public on June 15, 2023 in New York City.

Spencer Platt | Getty Images

Cava’s stock rose 7% Tuesday morning after the Mediterranean restaurant chain released its earnings report a day early.

Investors were expecting Cava to report its earnings after the bell on Tuesday afternoon, but the company issued its press release Monday evening instead after early versions of the results appeared in news reports shortly after market close.

Cava reported fourth-quarter net income of $2.05 million, or 2 cents per share, swinging from a net loss of $18.85 million, or $13.72 per share, a year earlier. Wall Street analysts surveyed by LSEG, formerly known as Refinitiv, were expecting the company to break even for the quarter.

The chain’s revenue soared 36% to $177.1 million, topping analysts’ expectations of $174 million. Cava’s same-store sales climbed 11.4%, crushing expectations of 5.9% growth, according to StreetAccount estimates.

For 2024, Cava is planning to open between 48 and 52 new locations. The company is forecasting same-store sales growth of 3% to 5% and adjusted earnings before interest, taxes, depreciation and amortization of $86 million to $92 million.

Cava’s shares have soared 145% since its initial public offering in June. Including Tuesday’s stock move, the restaurant chain has a market value of $6.14 billion.



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More